Initial observations on the administration of thymus extract (TFX) in patients with alimentary tract neoplasms.

L Cybulski, G Turowski, M Politowski, A Urban, T Turaszwili, M Zubel
{"title":"Initial observations on the administration of thymus extract (TFX) in patients with alimentary tract neoplasms.","authors":"L Cybulski,&nbsp;G Turowski,&nbsp;M Politowski,&nbsp;A Urban,&nbsp;T Turaszwili,&nbsp;M Zubel","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The administration of thymus extract (TFX) has been performed in 35 patients suffering from malignancies of the alimentary tract. TFX, being a calf thymuses extract prepared by Jelenia Góra Drug Producers \"Polfa\" was given in the dose of 0.5 mg in 3 or 7-day intervals during several months. The immunological condition of patients was checked by many tests: E-rosettes, DLT (direct lymphocytotoxicity test) determination of absolute number of peripheral blood lymphocytes and skin tests (RT-23, PHA and TFX). Our observations revealed that TFX is biologically active also in humans, increases cell-mediated immunity and may restore the immune capability of patients operated due to malignancies of the alimentary tract.</p>","PeriodicalId":20338,"journal":{"name":"Polish medical sciences and history bulletin","volume":"15 1","pages":"47-9"},"PeriodicalIF":0.0000,"publicationDate":"1976-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Polish medical sciences and history bulletin","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The administration of thymus extract (TFX) has been performed in 35 patients suffering from malignancies of the alimentary tract. TFX, being a calf thymuses extract prepared by Jelenia Góra Drug Producers "Polfa" was given in the dose of 0.5 mg in 3 or 7-day intervals during several months. The immunological condition of patients was checked by many tests: E-rosettes, DLT (direct lymphocytotoxicity test) determination of absolute number of peripheral blood lymphocytes and skin tests (RT-23, PHA and TFX). Our observations revealed that TFX is biologically active also in humans, increases cell-mediated immunity and may restore the immune capability of patients operated due to malignancies of the alimentary tract.

胸腺提取物(TFX)在消化道肿瘤患者中的应用的初步观察。
胸腺提取物(TFX)已在35例患有消化道恶性肿瘤的患者中进行。TFX是一种小牛胸腺提取物,由Jelenia Góra药物生产商“Polfa”在几个月内以3天或7天的间隔给予0.5毫克的剂量。通过e - rossettes、DLT(直接淋巴细胞毒性试验)测定外周血淋巴细胞绝对数量和皮肤试验(RT-23、PHA和TFX)等多种方法检查患者的免疫状况。我们的观察结果表明,TFX在人体中也具有生物活性,可以增强细胞介导的免疫,并可能恢复因消化道恶性肿瘤而手术的患者的免疫能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信